Vanda Pharmaceuticals (VNDA) Net Equity Issued and Repurchased (2010 - 2022)
Vanda Pharmaceuticals (VNDA) reported Net Equity Issued and Repurchased of $605,000 for Q4 2022, down 44.5% from $1.09 million a year earlier.
Vanda Pharmaceuticals (VNDA) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends
For FY2022, Vanda Pharmaceuticals posted Net Equity Issued and Repurchased of $734,000, down 79.6% from FY2021.
- Net Equity Issued and Repurchased has declined for four consecutive years, with a five-year compound annual growth rate of -32.7% (FY2017 to FY2022).
- By year, Net Equity Issued and Repurchased came in at $3.6 million in FY2021 (-36.1%), $5.63 million in FY2020 (-10.6%), $6.3 million in FY2019 (-93.8%) and $100.87 million in FY2018.
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$30,000 in Q2 2018 and a high of $100.9 million in Q1 2018.
- Year over year, Net Equity Issued and Repurchased has now declined in each of the last three quarters, with growth averaging 31.1% over the last seven quarters.
- The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2021 (growth of 269.8%); the low point was Q1 2019 (a decline of 99.8%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Vanda Pharmaceuticals | 279.91 Mn | -650.03 Mn | 46.97 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 289,000.00 |
| Mar 31, 2021 | 1.85 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | 102,000.00 |
| Jun 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 2.15 Mn |
| Sep 30, 2019 | 548,000.00 |
| Jun 30, 2019 | 3.40 Mn |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2017 | 130,000.00 |
| Sep 30, 2017 | 768,000.00 |
| Jun 30, 2017 | 2.19 Mn |
| Mar 31, 2017 | 2.21 Mn |
| Dec 31, 2016 | 799,000.00 |
Vanda Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VNDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();